W. Thomas Amick

W. Thomas Amick was appointed president and CEO of Dendreon Corporation in July 2014. “I have a great passion and respect for Dendreon’s mission of transforming the lives of patients through the discovery, development and commercialization of innovative cancer treatments,” Mr. Amick stated in a press release at the time of his progression. “I believe that PROVENGE is a unique immunotherapy treatment and look forward … Continue reading W. Thomas Amick